Market Overview:
The global lidocaine transdermal patch market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic pain, rising geriatric population, and growing demand for minimally invasive procedures. Based on type, the lidocaine transdermal patch market is segmented into lidocare 5% transdermal patch, lidocare 1.80% transdermal patch, and lidocare 4% transdermal patch. The lidocare 5%trans dermalpatch segment is expected to account for the largest share of the global market in 2018 owing to its high efficacy and better patient compliance as compared to other types of patches available in the market.
Product Definition:
Lidocaine Transdermal Patch is a prescription medicine that is used to treat mild to moderate pain.
Lidocare 5% Transdermal Patch:
Lidocaine 5% Transdermal Patch is used for the treatment of severe skin reactions, such as.
It's usage in Lidocaine transdermal patch market is projected to grow at a CAGR of XX% during the forecast period. The growth can be attributed to rising demand for efficient and long-acting local anesthetics with minimal side effects.
Lidocare 1.80% Transdermal Patch:
Lidocaine 1.80% transdermal patch is used for the treatment of moderate to severe pain. It’s a non-opioid drug, which works by changing the skin’s permeability to allow entry of medication into the bloodstream, thereby producing therapeutic effect on pain sensation.
The product was approved by Food and Drug Administration (FDA) in June 2016 as an alternative to oral tablets.
Application Insights:
Based on application, the global market is segmented into online pharmacies, hospital pharmacies, clinic and monomer pharmacies, chain pharmacies and others. The other segment held the largest share of the market in 2017 as a result of high usage rates for local anesthetics in various medical procedures such as dermal filler injections.
The online pharmacy segment is expected to grow at a lucrative rate over the forecast period due to increasing internet accessibility worldwide along with growing e-commerce industry. Moreover, lidocaine transdermal patches are available for purchase through online channels only; therefore no need to go through physical stores which increases their demand further. However, this method does have its disadvantages such as patchy availability across different regions due to limited manufacturing capacity and higher prices compared to that charged by clinics or hospitals which may deter consumers from using it extensively over the coming years.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing cases of chronic pain, rising awareness about alternative treatment options for common conditions such as arthritis and back pain, and growing preference for drug delivery systems such as transdermal patches over oral medication. In addition, presence of key players in this region with a focus on product innovation is also likely to contribute toward regional growth.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to factors such as improving healthcare infrastructure and rising disposable income especially in developing countries like China & India which are majorly driven by demand from online pharmacies due their convenience factor along with cost-effectiveness compared with other modes of delivery system (injection). Moreover, availability of generic lidocaine products at low prices will further drive regional growth over the coming years.
Growth Factors:
- Increasing incidence of chronic pain: The global prevalence of chronic pain is estimated to be around 20%. This number is expected to grow in the coming years due to the aging population and rising rates of lifestyle-related diseases. This will create a large pool of patients who can benefit from lidocaine transdermal patches.
- Growing awareness about lidocaine transdermal patches: There is a growing awareness among healthcare professionals and patients about the benefits of lidocaine transdermal patches over other forms of treatment for chronic pain. This is likely to drive demand for these products in the coming years.
- Availability of generic versions: A number of generic manufacturers have entered the market, offering low-cost alternatives to branded products. This will help make lidocaine transdermal patches more affordable and accessible to a larger population base worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Lidocaine Transdermal Patc Market Research Report
By Type
Lidocare 5% Transdermal Patch, Lidocare 1.80% Transdermal Patch, Lidocare 4% Transdermal Patch
By Application
Online Pharmacies, Hospital Pharmacies, Clinic, Monomer Pharmacies, Chain Pharmacies, Other
By Companies
Teikoku, Teva Pharmaceutical, Sorrento Therapeutics, Hisamitsu, Endo International, Par Pharmaceutical, Mylan, Tide Pharmaceutical (SINO BIOPHARM)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Lidocaine Transdermal Patc Market Report Segments:
The global Lidocaine Transdermal Patc market is segmented on the basis of:
Types
Lidocare 5% Transdermal Patch, Lidocare 1.80% Transdermal Patch, Lidocare 4% Transdermal Patch
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Online Pharmacies, Hospital Pharmacies, Clinic, Monomer Pharmacies, Chain Pharmacies, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Teikoku
- Teva Pharmaceutical
- Sorrento Therapeutics
- Hisamitsu
- Endo International
- Par Pharmaceutical
- Mylan
- Tide Pharmaceutical (SINO BIOPHARM)
Highlights of The Lidocaine Transdermal Patc Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Lidocare 5% Transdermal Patch
- Lidocare 1.80% Transdermal Patch
- Lidocare 4% Transdermal Patch
- By Application:
- Online Pharmacies
- Hospital Pharmacies
- Clinic
- Monomer Pharmacies
- Chain Pharmacies
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Lidocaine Transdermal Patc Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Lidocaine Transdermal Patches are a type of transdermal patch that releases the drug lidocaine through the skin. Lidocaine is a medication used to relieve pain and reduce inflammation.
Some of the major companies in the lidocaine transdermal patc market are Teikoku, Teva Pharmaceutical, Sorrento Therapeutics, Hisamitsu, Endo International, Par Pharmaceutical, Mylan, Tide Pharmaceutical (SINO BIOPHARM).
The lidocaine transdermal patc market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Lidocaine Transdermal Patc Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Lidocaine Transdermal Patc Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Lidocaine Transdermal Patc Market - Supply Chain
4.5. Global Lidocaine Transdermal Patc Market Forecast
4.5.1. Lidocaine Transdermal Patc Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Lidocaine Transdermal Patc Market Size (000 Units) and Y-o-Y Growth
4.5.3. Lidocaine Transdermal Patc Market Absolute $ Opportunity
5. Global Lidocaine Transdermal Patc Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Lidocaine Transdermal Patc Market Size and Volume Forecast by Type
5.3.1. Lidocare 5% Transdermal Patch
5.3.2. Lidocare 1.80% Transdermal Patch
5.3.3. Lidocare 4% Transdermal Patch
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Lidocaine Transdermal Patc Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Lidocaine Transdermal Patc Market Size and Volume Forecast by Application
6.3.1. Online Pharmacies
6.3.2. Hospital Pharmacies
6.3.3. Clinic
6.3.4. Monomer Pharmacies
6.3.5. Chain Pharmacies
6.3.6. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Lidocaine Transdermal Patc Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Lidocaine Transdermal Patc Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Lidocaine Transdermal Patc Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Lidocaine Transdermal Patc Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Lidocaine Transdermal Patc Demand Share Forecast, 2019-2026
9. North America Lidocaine Transdermal Patc Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Lidocaine Transdermal Patc Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Lidocaine Transdermal Patc Market Size and Volume Forecast by Application
9.4.1. Online Pharmacies
9.4.2. Hospital Pharmacies
9.4.3. Clinic
9.4.4. Monomer Pharmacies
9.4.5. Chain Pharmacies
9.4.6. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Lidocaine Transdermal Patc Market Size and Volume Forecast by Type
9.7.1. Lidocare 5% Transdermal Patch
9.7.2. Lidocare 1.80% Transdermal Patch
9.7.3. Lidocare 4% Transdermal Patch
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Lidocaine Transdermal Patc Demand Share Forecast, 2019-2026
10. Latin America Lidocaine Transdermal Patc Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Lidocaine Transdermal Patc Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Lidocaine Transdermal Patc Market Size and Volume Forecast by Application
10.4.1. Online Pharmacies
10.4.2. Hospital Pharmacies
10.4.3. Clinic
10.4.4. Monomer Pharmacies
10.4.5. Chain Pharmacies
10.4.6. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Lidocaine Transdermal Patc Market Size and Volume Forecast by Type
10.7.1. Lidocare 5% Transdermal Patch
10.7.2. Lidocare 1.80% Transdermal Patch
10.7.3. Lidocare 4% Transdermal Patch
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Lidocaine Transdermal Patc Demand Share Forecast, 2019-2026
11. Europe Lidocaine Transdermal Patc Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Lidocaine Transdermal Patc Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Lidocaine Transdermal Patc Market Size and Volume Forecast by Application
11.4.1. Online Pharmacies
11.4.2. Hospital Pharmacies
11.4.3. Clinic
11.4.4. Monomer Pharmacies
11.4.5. Chain Pharmacies
11.4.6. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Lidocaine Transdermal Patc Market Size and Volume Forecast by Type
11.7.1. Lidocare 5% Transdermal Patch
11.7.2. Lidocare 1.80% Transdermal Patch
11.7.3. Lidocare 4% Transdermal Patch
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Lidocaine Transdermal Patc Demand Share, 2019-2026
12. Asia Pacific Lidocaine Transdermal Patc Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Lidocaine Transdermal Patc Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Lidocaine Transdermal Patc Market Size and Volume Forecast by Application
12.4.1. Online Pharmacies
12.4.2. Hospital Pharmacies
12.4.3. Clinic
12.4.4. Monomer Pharmacies
12.4.5. Chain Pharmacies
12.4.6. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Lidocaine Transdermal Patc Market Size and Volume Forecast by Type
12.7.1. Lidocare 5% Transdermal Patch
12.7.2. Lidocare 1.80% Transdermal Patch
12.7.3. Lidocare 4% Transdermal Patch
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Lidocaine Transdermal Patc Demand Share, 2019-2026
13. Middle East & Africa Lidocaine Transdermal Patc Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Lidocaine Transdermal Patc Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Lidocaine Transdermal Patc Market Size and Volume Forecast by Application
13.4.1. Online Pharmacies
13.4.2. Hospital Pharmacies
13.4.3. Clinic
13.4.4. Monomer Pharmacies
13.4.5. Chain Pharmacies
13.4.6. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Lidocaine Transdermal Patc Market Size and Volume Forecast by Type
13.7.1. Lidocare 5% Transdermal Patch
13.7.2. Lidocare 1.80% Transdermal Patch
13.7.3. Lidocare 4% Transdermal Patch
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Lidocaine Transdermal Patc Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Lidocaine Transdermal Patc Market: Market Share Analysis
14.2. Lidocaine Transdermal Patc Distributors and Customers
14.3. Lidocaine Transdermal Patc Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Teikoku
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Teva Pharmaceutical
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Sorrento Therapeutics
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Hisamitsu
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Endo International
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Par Pharmaceutical
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Mylan
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Tide Pharmaceutical (SINO BIOPHARM)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
